Jussila L, Veikkola T, Jeltsch M, Thurston G, McDonald D, Achen M, ym..
Signalling via VEGFR-3 is sufficient for lymphangiogenesis in transgenic mice. Teoksessa Molecular Targets and Cancer Therapeutics: Discovery, Biology, and Clinical Applications. Miami Beach, Florida; 2001.
Määrittelemätön